180 Life Sciences Corp/$ETHZ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About 180 Life Sciences Corp
ETHZilla Corporation is a technology company in the decentralized finance industry. It seeks to connect financial institutions, businesses and organizations worldwide by enabling secure, accessible blockchain transactions through Ethereum Network protocol implementations. It generates recurring revenues through various DeFi protocols that improve Ethereum network integrity and security. The group enables the seamless tokenization of traditional assets by bringing them on-chain. Leveraging its proprietary protocol solutions, ETHZilla supports DeFi transactions, asset digitization across various Layer 2 Ethereum networks. The platform is focused on delivering tokenization services, DeFi protocol integrations, blockchain analytics, gateways for converting traditional assets to digital forms.
Ticker
$ETHZ
Sector
Primary listing
Employees
4
Headquarters
Website
ETHZ Metrics
BasicAdvanced
$317M
-
-$6.03
0.40
-
Price and volume
Market cap
$317M
Beta
0.4
52-week high
$17.46
52-week low
$0.66
Average daily volume
11M
Financial strength
Current ratio
0.58
Quick ratio
0.418
Total debt to equity
26.251
Interest coverage (TTM)
-230.45%
Profitability
EBITDA (TTM)
-6.449
Effective tax rate (TTM)
3.12%
Management effectiveness
Return on assets (TTM)
-55.46%
Return on equity (TTM)
-371.02%
Valuation
Price to book
2.22
Price to tangible book (TTM)
-5.33
Price to free cash flow (TTM)
-1.791
Free cash flow yield (TTM)
-55.84%
Free cash flow per share (TTM)
-1.106
Growth
Earnings per share change (TTM)
-68.64%
3-year earnings per share growth (CAGR)
-71.71%
Bulls say / Bears say
ETHZilla’s strategic shift has built nearly $350 million in Ether reserves, strengthening its balance sheet and putting it among the top corporate ETH treasury holders (Investopedia)
The Board’s $250 million share buyback approval shows management’s belief that the stock is undervalued and signals a commitment to shareholder returns (Investopedia)
Collaborations with liquid restaking protocols—including allocating $47 million of ETH to Puffer—demonstrate ETHZilla’s innovative efforts to boost returns on its ETH holdings (Investing.com)
The $250 million buyback is being funded with $80 million in debt, raising concerns about higher leverage and reduced financial flexibility in the face of volatile crypto markets (Financial Times)
The stock saw sharp intraday volatility—jumping 14 percent before closing down 3 percent—which highlights ongoing investor doubt regarding the viability of its crypto treasury strategy (Investopedia)
The recent $350 million convertible debenture issuance, convertible at $3.05 per share (1.05× NAV), could dilute current shareholders if fully converted (Nasdaq Press Release)
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.
ETHZ News
AllArticlesVideos
New Ether Treasury ETHZilla Stock Jumps on Buyback Program
Investopedia2 months ago
Stock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus
Benzinga2 months ago
Palantir co-founder Peter Thiel buys into crypto firm as stock soars 250%
Finbold2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for 180 Life Sciences Corp stock?
180 Life Sciences Corp (ETHZ) has a market cap of $317M as of October 12, 2025.
What is the P/E ratio for 180 Life Sciences Corp stock?
The price to earnings (P/E) ratio for 180 Life Sciences Corp (ETHZ) stock is 0 as of October 12, 2025.
Does 180 Life Sciences Corp stock pay dividends?
No, 180 Life Sciences Corp (ETHZ) stock does not pay dividends to its shareholders as of October 12, 2025.
When is the next 180 Life Sciences Corp dividend payment date?
180 Life Sciences Corp (ETHZ) stock does not pay dividends to its shareholders.
What is the beta indicator for 180 Life Sciences Corp?
180 Life Sciences Corp (ETHZ) has a beta rating of 0.4. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.